OptimizeRx Corp

OptimizeRx Corp. is digital health company, engaging in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

OptimizeRx Corp exceeds revenue expectations, eyes growth through strategic deals

OptimizeRx Corp's strong revenue performance and focus on Real-World Data deals position them for growth despite challenges in revenue retention and operating expenses.
The company's strategic initiatives, including share repurchase, capacity utilization, and omnichannel expansion, showcase resilience and potential for market capture.
By leveraging RWD-AI models, focusing on strategic partnerships, and expanding service offerings, OptimizeRx aims to achieve financial and operational goals in 2023.

OptimizeRx Corp reports solid Q1 performance and eyes growth opportunities

OptimizeRx Corp (OPRX) reported solid Q1 performance, meeting revenue expectations and maintaining full-year outlook with a 10% YoY increase expected. The company showcased strengths in strategic partnerships, RWD-AI solutions, and effective use cases for RWE products.
Despite challenges in operating expenses and net revenue retention rate decline, the company is focused on innovation and growth opportunities through M&A, technology investments, and service expansion. By addressing challenges and leveraging opportunities, OptimizeRx Corp aims for sustainable growth and market differentiation.
With a strong emphasis on product execution, customer ROI, and shareholder value enhancement through a share repurchase program, OptimizeRx Corp is positioning itself for continued success in the healthcare technology sector. The company's strategic initiatives and focus on revenue diversification signal a promising outlook for future growth.

OptimizeRx Corp reports Q2 results, focuses on AI growth

OptimizeRx Corp navigated challenges in Q2 2023 with a focus on financial stability, operational efficiency, and strategic growth initiatives.
Despite disappointment with results, the company remains optimistic about the future of digital marketing in healthcare and the potential of AI-driven solutions.
With a strong balance sheet, emphasis on core business areas, and plans for cost management, OptimizeRx is positioned to capitalize on growth opportunities.
The company's commitment to renewals, upsells, and AI-driven engagement underscores a proactive approach to revenue retention and customer satisfaction.

OptimizeRx Corp (OPRX) beats Q3 expectations, eyes robust 2024 growth

OptimizeRx's Q3 performance exceeded expectations, showcasing strong financials and strategic acquisitions driving growth. While competitors face challenges, OptimizeRx is poised for further expansion and revenue increase in 2024 through enhanced platforms and market opportunities.

OptimizeRx Corp exceeds revenue expectations, eyes $100M target in 2024

OptimizeRx Corp delivered exceptional Q4 2023 results, driven by organic messaging strength and the Medicx Health acquisition.
The company's focus on digital solutions and strategic partnerships positions it well for future growth and capturing pharma spend.
While facing macroeconomic challenges, OptimizeRx's progress in Medicx Health integration and DAAP platform growth present promising opportunities.

OptimizeRx Corp reports robust Q1 performance, eyes sustained growth

OptimizeRx Corp's Q1 2024 performance reflects strong revenue growth, improved gross margin, and positive operating cash flow, underpinned by a focus on DAAP and stakeholder engagement.
While facing challenges in profitability and seasonality impact, the company remains optimistic about scaling DAAP, accelerating revenue growth, and enhancing performance in the second half of the year.
With opportunities to drive revenue through cross-selling, expanding infrastructure, and leveraging AI models, OptimizeRx is poised for sustainable growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

ROCHESTER, Mich., April  16, 2020  (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will continue its webinar series on COVID-19 next week to address the rapid adoption of telehealth with industry veterans from Carla Smith Health and  Genius Rx .

OptimizeRx Continues COVID-19 Webinar Series, Addressing the Rapid Adoption of Telehealth

ROCHESTER, Mich., April  08, 2020  (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has received the ranking of #282 by the Financial Times’ 2020 list of The Americas' 500 Fastest-Growing Companies .

OptimizeRx Recognized as One of The Americas’ Fastest-Growing Companies by The Financial Times

On-Demand Virtual Consults with Medical Science Liaisons Help Providers Create the Right Treatment Regimen for Patients Needing Specialty Drugs On-Demand Virtual Consults with Medical Science Liaisons Help Providers Create the Right Treatment Regimen for Patients Needing Specialty Drugs

OptimizeRx Launches TelaRep™ to Support Physicians Treating Patients with Complex Diseases in COVID-19 World 

Session to Focus on Frontline Healthcare Provider Communication During the COVID-19 Pandemic Session to Focus on Frontline Healthcare Provider Communication During the COVID-19 Pandemic

OptimizeRx Continues Coronavirus Conversation Series with Leaders of NextGen and Illumina

ROCHESTER, Mich., March  15, 2020  (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has launched a free interactive text message alert program available to the general public that delivers coronavirus (COVID-19) information issued by the Centers for Disease Control and Prevention (CDC) directly to any SMS-enabled mobile device.

OptimizeRx Launches Coronavirus Text Message Alerts

ROCHESTER, Mich., March  11, 2020  (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has secured two additional enterprise-level engagements, expanding access for two clients across the entire OptimizeRx platform.

OptimizeRx Secures Two Additional Enterprise Clients on Newly Integrated Digital Healthcare Platform

First of Three Sessions Begins Today at 11:30 a.m. Eastern Time First of Three Sessions Begins Today at 11:30 a.m. Eastern Time

OptimizeRx Launches ‘Digital Healthcare’ Webinar Series

ROCHESTER, Mich., March  09, 2020  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has integrated alerts from the Centers for Disease Control and Prevention (CDC) for Coronavirus (COVID-19) into its digital health information network deployed by leading electronic health record (EHR) providers nationwide.

OptimizeRx Digital Health Network Now Delivering CDC Coronavirus Alerts to Thousands of Healthcare Providers Nationwide

ROCHESTER, Mich., March  02, 2020  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for pharmaceutical companies, payers, medtech and medical associations, has appointed  Todd Inman  as chief technology officer.

OptimizeRx Appoints Todd Inman as Chief Technology Officer

OptimizeRx: A Small Company With Big Potential

OptimizeRx Corporation (OPRX) CEO William Febbo on Q4 2019 Results - Earnings Call Transcript

First Solution from the OptimizeRx Innovation Lab Ensures that Patient Access to Specialty Drugs Is Expedited First Solution from the OptimizeRx Innovation Lab Ensures that Patient Access to Specialty Drugs Is Expedited

OptimizeRx Launches EHR-Enabled Specialty Hub Enrollment Form

ROCHESTER, Mich., Jan.  29, 2020  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has sealed its largest ever enterprise deal for 12 months of access to its platform and core set of solutions.

OptimizeRx Seals Multi-Million Dollar Enterprise Deal for Integrated Platform

OptimizeRx Corp.: Optimize Your Portfolio With This Under The Radar Health Tech Company

ROCHESTER, Mich., Dec.  09, 2019  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (NASDAQ: OPRX), a leading provider of digital health solutions for pharmaceutical companies, payers, medtech and medical associations, reported its sales pipeline, which is comprised of outstanding request for proposals (RFPs) submitted, has increased 79% to $84 million in 2019 as compared to last year. The company’s RFPs have historically realized a 35%-50% close rate.

OptimizeRx Sales Pipeline Up 79% to $84 Million in 2019; Company Reiterates Strong Q4 and 2020 Outlook

OptimizeRx Corporation (OPRX) CEO William Febbo on Q3 2019 Results - Earnings Call Transcript

ROCHESTER, Mich., Oct.  28, 2019  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for pharmaceutical companies, payers, medtech and medical associations, has integrated its core set of solutions into a single platform to more effectively address the need for greater patient-provider-pharma-payer collaboration and improvement in medication affordability and adherence.

OptimizeRx Launches Newly Integrated Platform to Improve Outcomes

ROCHESTER, Mich., Oct.  21, 2019  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, is sponsoring the  WOMEN at HLTH  program at  HLTH 2019 , the nation’s largest conference focused on health innovation. The conference is being held on October 27-30, 2019 at the MGM Grand in Las Vegas.

OptimizeRx Sponsors WOMEN at HLTH Program at the 2019 HLTH Conference

ROCHESTER, Mich., Oct.  07, 2019  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (NASDAQ: OPRX), a leading provider of digital health solutions for payers, medtech companies, medical associations and the pharmaceutical industry, has secured a three-year exclusive partnership with  NewCrop , a provider of integrated electronic prescribing software, to deliver real-time digital health messages to NewCrop’s e-prescribing network of more than 65,000 healthcare professionals.

OptimizeRx Signs Exclusive Agreement with NewCrop to Offer Digital Health Messages and Create a Health Tech Innovation Lab for Life Sciences

ROCHESTER, Mich., Sept.  10, 2019  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will host two plenary sessions at the  13  th   Annual Digital Pharma East  conference being held at the Pennsylvania Convention Center in Philadelphia on September 17-20, 2019.

OptimizeRx Invited to Host Plenary Sessions at Digital Pharma East on September 17-20, 2019

Digital Turbine

Eldorado Gold

Perion Network

Controladora Vuela Cia de Aviacion SAB de CV

This method involved zeroing in on those stocks whose prices are varying within a narrow band.

5 Breakout Stocks - for Explosive Returns

Acquisition to Enhance OptimizeRx Existing Digital Platform with Technology Solutions Tailored for Digital Therapeutics; Extends Offerings to SaaS-based Patient Engagement Markets Acquisition to Enhance OptimizeRx Existing Digital Platform with Technology Solutions Tailored for Digital Therapeutics; Extends Offerings to SaaS-based Patient Engagement Markets

OptimizeRx to Acquire Digital Therapeutics SaaS Platform Provider, RMDY Health

ROCHESTER, Mich., Aug.  29, 2019  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in the Lake Street Capital Markets 3rd Annual  Best Ideas Growth (BIG3) Conference  being held on September 12, 2019 at the Parker New York.

OptimizeRx to Participate at Lake Street Annual Best Ideas Growth Conference on September 12, 2019

OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2019 Results - Earnings Call Transcript

Is  (OPRX) Outperforming Other Computer and Technology Stocks This Year?

News for OptimizeRx Corp Stock (OPRX)